October 24, 2017 8:21 AM ET

Life Sciences Tools and Services

Company Overview of Labcyte Inc.

Company Overview

Labcyte Inc., a biotechnology tools company, manufactures and delivers instruments that are used worldwide throughout the pharmaceutical industry, as well as by biotechnology companies, contract research organizations, and academic institutions. It offers Echo 525, a liquid handler that is designed primarily for biochemical and genomics reagent transfer; and Echo 550, a liquid handler for medium throughput screening and large genomics projects. The company also provides Access laboratory workstation, a ready-to-go robotic system for echo liquid handlers; POD automation platform for maximum throughput and capacity; Tempo, an automation control software that enables design and scheduling for c...

170 Rose Orchard Way

San Jose, CA 95134

United States

Founded in 2000





Key Executives for Labcyte Inc.

Chief Executive Officer, President and Director
Age: 60
Founder, Chief Technology Officer and Director
Vice President of Finance
Age: 51
Managing Director of Europe Limited
Age: 59
Compensation as of Fiscal Year 2017.

Labcyte Inc. Key Developments

Labcyte Introduces New 384-Well Low Dead Volume Microplate for Echo® 525 Liquid Handlers

Labcyte Inc. announced the release of a new 384-well low dead volume microplate for its Echo® 525 Liquid Handlers. The new Echo® Qualified 384 LDV Plus Microplate reduces the amount of sample or reagent required in a well for transfer by 75% or more. Labcyte’s Echo 525 Liquid Handlers use focused sound energy to dispense precisely sized 25nL droplets of samples or reagents from microplate to microplate without the contact of tips or nozzles. Larger volume transfers are achieved by transferring several hundred droplets per second. This reduces costs by allowing miniaturization and leads to improved results by eliminating the contamination risks associated with tips. The speed at which Echo systems transfer fluid from any well on a microplate to any well on another microplate has driven its adoption for pooling in synthetic biology and genomics applications where DNA oligos, sequencing libraries and PCR primers are pooled in random combinations. With the ability to miniaturize reaction volumes while improving experimental outcomes, Echo system users in academic institutions as well as industrial biotechnology and pharmaceutical companies experience immediate improvements in efficiency and productivity.

Labcyte and SEngine Precision Medicine Collaborate to Offer Functional Drug Screening for Oncology

Labcyte Inc. and SEngine Precision Medicine announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte's advanced acoustic liquid handling solutions with SEngine's unique functional drug testing approach with the mission to match cancer patients to the most effective and least toxic therapies available. SEngine employs functional genomics and robotic testing of drugs in live patient organoids using the company's CLIA-certified P.A.R.I.S. assay. From a single sample taken from a patient's tumor, SEngine scientists can discover which drugs or combinations of drugs are most effective in killing or disabling that individual's cancer, and which therapies will most likely not work in a specific case - saving patients time, money, and unnecessary side effects. The test employs more than 100 drugs, carefully selected to include the and most up-to-date collection of targeted therapies, and is applicable to all major solid tumor types. Labcyte's Echo Liquid Handlers use the gentle energy of sound waves to transfer liquids with high accuracy and billionth of a liter precision. The ability to miniaturize and automate assays saves scientists time and money, and enables new types of assays that were previously inconceivable or too difficult with traditional methods. Acoustic liquid handling technology is contactless, eliminating the use of pipettes and reducing the volumes required for compounds and samples. SEngine is also using Labcyte's Access Laboratory Workstation to further automate its lab and increase throughput while preserving accuracy.

Labcyte Moves Global Headquarters to 60,000 Square Foot Building in San Jose

Labcyte Inc. relocated its global headquarters to San Jose, California, taking over a 60,000 square foot building at 170 Rose Orchard Way.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Private Placement
December 23, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Labcyte Inc., please visit www.labcyte.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.